Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety.

Those who developed CsA-ARI had the highest baseline eGFR, older age, more frequency of artery lesions, and higher peak serum cyclosporine levels, whereas the differences did not reach statistical significance.

also in 111,027 other papers